ANI Pharmaceuticals, Inc.
ANIP
$63.26
$1.863.03%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -1.38% | -37.96% | 3.69% | 7.75% | 14.52% |
| Total Receivables | 12.92% | 18.22% | -3.67% | 6.38% | -9.37% |
| Inventory | -7.61% | 18.01% | 10.20% | 2.38% | 4.32% |
| Prepaid Expenses | 2.89% | 26.09% | -13.01% | -9.48% | 65.87% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -96.32% | 100.16% | 955.67% | -96.26% | -2.43% |
| Total Current Assets | 1.23% | -6.15% | 2.76% | 3.99% | 4.54% |
|
|
|||||
| Total Current Assets | 1.23% | -6.15% | 2.76% | 3.99% | 4.54% |
| Net Property, Plant & Equipment | 0.28% | 9.81% | 6.42% | 8.82% | 0.91% |
| Long-term Investments | -0.72% | 114.12% | 0.00% | 0.00% | 0.00% |
| Goodwill | -0.72% | 114.12% | 0.00% | 0.00% | 0.00% |
| Total Other Intangibles | -4.91% | 211.25% | -6.61% | -6.20% | -4.92% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 22.38% | -20.46% | 1.58% | -3.18% | 6.73% |
| Total Assets | -0.29% | 39.82% | 0.68% | 1.12% | 1.63% |
|
|
|||||
| Total Accounts Payable | -25.02% | 25.08% | -1.52% | 34.75% | 7.65% |
| Total Accrued Expenses | 8.64% | 49.96% | 32.83% | -27.48% | 33.10% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 56.75% | 741.41% | 0.00% | 0.00% | 0.00% |
| Total Finance Division Other Current Liabilities | 20.08% | 10.40% | -22.23% | -10.85% | -10.48% |
| Total Other Current Liabilities | 20.08% | 10.40% | -22.23% | -10.85% | -10.48% |
| Total Current Liabilities | 1.97% | 35.69% | 2.26% | -5.90% | 8.28% |
|
|
|||||
| Total Current Liabilities | 1.97% | 35.69% | 2.26% | -5.90% | 8.28% |
| Long-Term Debt | -0.53% | 117.38% | -0.07% | -0.07% | -0.07% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -34.49% | 48.41% | -7.44% | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 1.27% | 274.06% | -0.61% | -32.47% | 56.51% |
| Total Liabilities | -0.16% | 94.61% | 0.56% | -2.04% | 2.67% |
|
|
|||||
| Common Stock & APIC | 1.71% | -4.06% | 1.69% | 1.85% | 1.50% |
| Retained Earnings | -11.92% | -37.79% | -4.32% | 22.21% | 0.92% |
| Treasury Stock & Other | -2.21% | -31.09% | -25.47% | -662.75% | -128.96% |
| Total Common Equity | -0.56% | -10.93% | 0.84% | 4.44% | 0.67% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
|
|
|||||
| Total Common Equity | -0.56% | -10.93% | 0.84% | 4.44% | 0.67% |
| Total Preferred Equity | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -0.53% | -10.36% | 0.80% | 4.20% | 0.64% |
|
|
|||||
